Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
This study is ongoing, but not recruiting participants.
Sponsor:
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Collaborator:
Pfizer
Information provided by (Responsible Party):
National Surgical Adjuvant Breast and Bowel Project (NSABP)
ClinicalTrials.gov Identifier:
NCT01423123
First received: August 19, 2011
Last updated: September 24, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2013 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |